ANDA 210275

MYLAN

FDA Drug Application

Application #210275

Application Sponsors

ANDA 210275

MYLAN

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003
• Prescription: 004

Application Products

001	CAPSULE;ORAL	1MG	0	POMALIDOMIDE	POMALIDOMIDE
002	CAPSULE;ORAL	2MG	0	POMALIDOMIDE	POMALIDOMIDE
003	CAPSULE;ORAL	3MG	0	POMALIDOMIDE	POMALIDOMIDE
004	CAPSULE;ORAL	4MG	0	POMALIDOMIDE	POMALIDOMIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2022-01-26

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB
004	Prescription	AB

CDER Filings

MYLAN

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210275
            [companyName] => MYLAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"1MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"2MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"3MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"POMALIDOMIDE","activeIngredients":"POMALIDOMIDE","strength":"4MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/26\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-01-26
        )

)